Product Description
Pentazocine injection is used to relieve moderate to severe pain. It may also be used before surgery or with a general anesthetic (medicine that puts you to sleep). Pentazocine belongs to the group of medicines called narcotic analgesics (pain medicines). It acts on the central nervous system (CNS) to relieve pain. (Sourced from: https://www.mayoclinic.org/drugs-supplements/pentazocine-injection-route/side-effects/drg-20074265?p=1)
Mechanisms of Action: OPRK Agonist,OPRM Antagonist
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Intravenous,Intramuscular,Oral
FDA Designation: *
Approval Status: Approved
Approved Countries: Australia | Bangladesh | Canada | Greece | India | Ireland | Italy | Korea | Malaysia | New Zealand | Pakistan | Peru | Poland | Portugal | Slovenia | South Africa | Taiwan | United Kingdom | United States
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|